Lindbrook Capital’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SW
Lindbrook Capital's ASTH Position: Q1 2025 in Review
Lindbrook Capital reduced its Astrana Health (ASTH) stake by 4.2% in Q1 2025, selling an estimated $133 and leaving 92 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.
Lindbrook Capital first reported a position in ASTH in Q1 2020 and has held it in 21 quarters since. The position peaked at $53K in Q4 2021. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.
- Lindbrook Capital held 92 shares of Astrana Health worth $2.85K as of Q1 2025.
- Lindbrook Capital sold 4 Astrana Health shares in Q1 2025, an estimated $133.
- Astrana Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2169 holding.
- Lindbrook Capital first reported a position in Astrana Health in Q1 2020 and has held it in 21 quarters since.
- Lindbrook Capital's Astrana Health position peaked at $53K in Q4 2021.
- 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.